Develops oral appliances that treat obstructive sleep apnea in adults.
Jun 2026Revenue $20.9M/yrExpenses $43.5M/yr
No trendCash runway ≈ 1 month from Jun 2026
Figures by year
When will Vivos Therapeutics be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $20.9M and expenses $43.5M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $17.4M | $37.3M | −$19.9M |
| Dec 2024 | $15.0M | $26.2M | −$11.2M |
| Dec 2023 | $13.8M | $31.1M | −$17.3M |
| Dec 2022 | $16.0M | $41.1M | −$25.0M |
| Dec 2021 | $16.9M | $37.3M | −$20.4M |
| Dec 2020 | $13.1M | $25.1M | −$12.0M |
| Dec 2019 | $11.4M | $22.0M | −$10.6M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.